Jasper Therapeutics, Inc.

General ticker "JSPR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $246.9M (TTM average)

Jasper Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -0.1%.

Estimated limits based on current volatility of 4.6%: low 4.84$, high 5.31$

Factors to consider:

  • Earnings expected soon, date: 2025-05-13 bmo
  • Current price 55.4% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [12.30$, 33.78$]
  • 2025-12-31 to 2026-12-31 estimated range: [7.52$, 22.35$]

Financial Metrics affecting the JSPR estimates:

  • Negative: Non-GAAP EPS, $ of -4.86 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -16.21 <= 1.79
  • Negative: negative Operating income
  • Negative: negative Industry operating income (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Shareholder equity ratio, % of 77.19 > 63.75

Similar symbols

Short-term JSPR quotes

2025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-3033.544.555.5
Price $

Long-term JSPR plot with estimates

5101520253035Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1.5−1−0.50
JSPRS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $51.20MM $68.86MM $76.24MM
Operating Income $-51.20MM $-68.86MM $-76.24MM
Non-Operating Income $13.51MM $4.36MM $4.97MM
R&D Expense $34.63MM $51.78MM $55.82MM
Income(Loss) $-37.69MM $-64.50MM $-71.27MM
Profit(Loss)* $-24.17MM $-64.47MM $-71.27MM
Stockholders Equity $35.99MM $78.44MM $61.67MM
Assets $48.36MM $94.89MM $79.90MM
Operating Cash Flow $-45.86MM $-52.07MM $-62.60MM
Capital expenditure $0.58MM $0.27MM $0.55MM
Investing Cash Flow $-0.58MM $-0.27MM $-0.53MM
Financing Cash Flow $0.06MM $100.97MM $47.88MM
Earnings Per Share** $-6.63 $-6.18 $-4.89

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.